Samuel N. Hazen - Oct 31, 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
CEO, Director
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Oct 31, 2025
Transactions value $
-$8,911,446
Form type
4
Date filed
11/4/2025, 06:16 PM
Previous filing
May 15, 2025
Next filing
Nov 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAZEN SAMUEL N CEO, Director ONE PARK PLAZA, NASHVILLE /s/ Kevin A. Ball, Attorney-in-Fact 2025-11-04 0001216838

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $4.04M +58.1K +336.93% $69.58 75.3K Oct 31, 2025 Direct
transaction HCA Common Stock Tax liability -$13M -28.2K -37.42% $459.68 47.1K Oct 31, 2025 Direct
holding HCA Common Stock 15K Oct 31, 2025 By HD Trust
holding HCA Common Stock 16.7K Oct 31, 2025 By 2023 GST Trust
holding HCA Common Stock 93.1K Oct 31, 2025 By 2023 Trust
holding HCA Common Stock 178K Oct 31, 2025 By 2024 GRAT
holding HCA Common Stock 200K Oct 31, 2025 By 2025 GRAT
holding HCA Common Stock 813K Oct 31, 2025 By LP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -58.1K -100% $0.00 0 Oct 31, 2025 Common Stock 58.1K $69.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.